473416-22-7

Basic information

• Product Name: 1H-INDAZOLE-1-CARBOXYLIC ACID,3-BROMO-5-NITRO-,1,1-DIMETHYLETHYL ESTER
• Synonyms: 1H-INDAZOLE-1-CARBOXYLIC ACID,3-BROMO-5-NITRO-,1,1-DIMETHYLETHYL ESTER;1-Boc-3-broMo-5-nitro-1H-indazole;tert-butyl 3-broMo-5-nitro-1H-indazole-1-carboxylate;1,1-Dimethylethyl 3-bromo-5-nitro-1H-indazole-1-carboxylate
• CAS NO: 473416-22-7
• Molecular Formula: C₁₂H₁₂BrN₃O₄
• Molecular Weight: 342.15
• Mol File: 473416-22-7.mol
• Article Data: 4

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 1H-INDAZOLE-1-CARBOXYLIC ACID,3-BROMO-5-NITRO-,1,1-DIMETHYLETHYL ESTER(CAS DataBase Reference)
• NIST Chemistry Reference: 1H-INDAZOLE-1-CARBOXYLIC ACID,3-BROMO-5-NITRO-,1,1-DIMETHYLETHYL ESTER(473416-22-7)
• EPA Substance Registry System: 1H-INDAZOLE-1-CARBOXYLIC ACID,3-BROMO-5-NITRO-,1,1-DIMETHYLETHYL ESTER(473416-22-7)

Safety Data

• Hazardous Substances Data: 473416-22-7(Hazardous Substances Data)

Usage

General Description

1H-Indazole-1-carboxylic acid, 3-bromo-5-nitro, 1,1-dimethylethyl ester is a chemical compound with the formula C14H17BrN4O4. It is an ester derivative of 1H-indazole-1-carboxylic acid and is used in organic synthesis and medicinal chemistry research. It is commonly used as a building block for the synthesis of pharmaceutical compounds and agrochemicals. 1H-INDAZOLE-1-CARBOXYLIC ACID,3-BROMO-5-NITRO-,1,1-DIMETHYLETHYL ESTER is a nitro-substituted indazole carboxylic acid ester with potential antineoplastic and antimetabolite properties. Additionally, it has shown potential antifungal and anticancer activity in various studies.

Upstream product

• 5401-94-5 5-nitroindazole 
• 67400-25-3 3-bromo-5-nitro-1H-indazole 
• 24424-99-5 di-tert-butyl dicarbonate 

Downstream Products

• 1093061-47-2 (S)-N-(3-(4-fluorophenyl)-1H-indazol-5-yl)-3-(methylthio)-1-(2-oxo-2-(4-(4-(pyrimidin-2-yl)phenyl)-3,6-dihydropyridin-1(2H)-yl)ethyl)pyrrolidine-3-carboxamide 
• 1093063-68-3 C₁₉H₁₉FN₄OS 

Relevant articles and documents

HETEROCYCLIC COMPOUNDS AS KINASE INHIBITORS

Heterocyclic compounds as CDK4 or CDK6 or other CDK inhibitors are provided. The compounds may find use as therapeutic agents for the treatment of diseases and may find particular use in oncology.

Discovery of 3(S)-thiomethyl pyrrolidine ERK inhibitors for oncology

Compound 5 (SCH772984) was identified as a potent inhibitor of ERK1/2 with excellent selectivity against a panel of kinases (0/231 kinases tested @ 100 nM) and good cell proliferation activity, but suffered from poor PK (rat AUC PK @10 mpk = 0 μM h; F% =